SPIRE-LL
STUDY TO ASSESS THE EFFICACY, SAFETY AND TOLERABILITY OF PF-04950615 IN SUBJECTS WITH PRIMARY HYPERLIPIDEMIA OR MIXED DYSLIPIDEMIA AT RISK OF CARDIOVASCULAR EVENTS
- Stadium
- klaar
- Middel
- PF-04950615 (PCSK9)
- Populatie
- Primaire preventie coronairlijden
- Fase
- III
- First Patient In
- 31 januari 2015
- Last Patient In
- 31 mei 2015
- Last Patient Last Visit
- 1 september 2016
Studiedirecteur
